CURATED HEALTH UPDATES
Growing Concern: Burden of Diabetes and Hyperglyce
Growing Concern: Burden of Diabetes and Hyperglycemia in the Americas

The burden of diabetes continues to escalate, presenting a significant and expanding challenge across the Americas.

April 2023

Combined Therapy Shows Promise in Benign Prostatic
Combined Therapy Shows Promise in Benign Prostatic Hyperplasia Management

Tamsulosin plus dutasteride combination therapy demonstrates significant potential in reducing the risk of symptom progression and acute urinary retention in benign prostatic hyperplasia patients.

April 2023

EMA Recommends Approval of Imvanex Vaccine for Mon
EMA Recommends Approval of Imvanex Vaccine for Monkeypox

Imvanex vaccine receives EMA's recommendation for approval, aiming to extend its usage for monkeypox, leveraging its prior approval against smallpox.

April 2023

Pulmonary Hypertension Requires Earlier Diagnosis
Pulmonary Hypertension Requires Earlier Diagnosis

“The Diagnosis of Pulmonary Hypertension, and Therefore the Initiation of Appropriate Treatment, Is Often Considerably Delayed”

April 2023

Air Pollution May Promote Arrhythmias in Healthy A
Air Pollution May Promote Arrhythmias in Healthy Adolescents

Wearing face masks and avoiding vigorous physical activity may be justified.

April 2023

COVID-19: United Kingdom Approves “Double” Vac
COVID-19: United Kingdom Approves “Double” Vaccine

Protects Against the Original Wuhan Form of the SARS-CoV-2 Virus and the First Omicron Variant (BA. 1). They Estimate That the First Doses Could Be Applied at the End of September

April 2023

Needle-Free Nasal COVID-19 Vaccine Shows Promise
Needle-Free Nasal COVID-19 Vaccine Shows Promise

A highly effective, needle- and adjuvant-free, bacteriophage-based mucosal COVID-19 vaccine demonstrates potential as an alternative vaccination approach.

April 2023

Monkeypox: Positive Samples in Asymptomatic People
Monkeypox: Positive Samples in Asymptomatic People

The Possibility of Asymptomatic Infection Is Another Concern in the Monkeypox Outbreak

April 2023

Metformin, Ivermectin, and Fluvoxamine for Covid-1
Metformin, Ivermectin, and Fluvoxamine for Covid-19

None of the Three Drugs in the Trial Prevented a Primary Event

April 2023

Illicit Drug Use and Cardiovascular Risk in the IC
Illicit Drug Use and Cardiovascular Risk in the ICU

Illicit Drug Use Has Increased by 22% in the Last Decade to an Estimated 275 Million People Worldwide

April 2023